-
The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs
02 Oct 2020 11:46 GMT
… Genomics Inc (NASDAQ: TXG)
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) ( moved on M … in patients with neuroendocrine tumors.
IPOs
Exton, Pennsylvania-based Immunome, Inc … antibody therapeutics, priced its upsized initial public offering, or IPO, of 3.25 million …
-
The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
01 Oct 2020 13:07 GMT
… TCDA)
Stocks In Focus
Amag Reportedly Pursued By Apollo… s Covis Pharma
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) shares surged … with Duchenne muscular dystrophy.
IPOs
Pulmonx Corporation, a … upsized 10-million-share initial public offering at $19 each …
-
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
06 Aug 2020 12:14 GMT
… ) (before the market open)
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) (before the market … (NASDAQ: NKTR) (after the close)
IPOs
Acutus Medical, Inc., an arrhythmia … diagnosed and treated, priced its initial public offering of 8.824 million shares …
-
The Daily Biotech Pulse: Sorrento Submits EUA Application For Rapid Coronavirus Test, Decision Day For Viela, Lantern Pharma IPO
11 Jun 2020 12:22 GMT
… , Hematology Conference Take Center Stage
Amag Announces Abrupt Departure Of CFO … : ADXS) (before the market opens)
IPO
Dallas, Texas-based clinical-stage … oncology therapies, priced its upsized initial public offering of 1.75 million shares …
-
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More
12 Jun 2020 13:59 GMT
… .
THIS WEEK IN BIOTECH IPOS
—Legend Biotech (NASDAQ: LEGN … decisions, filed for an IPO targeting $100 million.
— … $200 million in its IPO.
—China-based cancer diagnostics … chief medical officer… AMAG Pharmaceuticals (NASDAQ: [[ticker:[[AMAG]]) appointed Brian …
-
ADCT Closes IPO, ALDX To Provide COVID-19 Update, RWLK To Focus On Telehealth
20 May 2020 02:55 GMT
… news about ADC Therapeutics' IPO; Aldeyra Therapeutics' COVID-19 … on…
1. Swiss biotech closes IPO
Swiss biotech ADC Therapeutics SA … 19 each, has closed its IPO, raising gross proceeds of about … 30% at $3.40
AMAG Pharmaceuticals Inc. (AMAG): Up 19.70% at …
-
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
07 Mar 2020 07:14 GMT
… gander at companies laying IPO plans amid uneven market … end.
THIS WEEK IN IPOs
—South San Francisco-based … $86 million for its initial public offering. ORIC stands for “overcoming … chief medical officer of AMAG Pharmaceuticals (NASDAQ: AMAG) is stepping down… …
-
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12 Mar 2020 12:09 GMT
… Plc (NASDAQ: ALKS)
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG)
Amarin Corporation plc (NASDAQ … close)
• Synlogic (after the close)
IPOs
Imara, a biopharma company that … rare hemoglobinopathies, priced its upsized IPO of 4.70 million shares …
-
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More
10 Jan 2020 14:04 GMT
… FDA, and another biotech revealed IPO plans. Let’s get to … Therapeutics revealed plans for an IPO to take its lead cancer … due to safety concerns.
—AMAG Pharmaceuticals (NASDAQ: AMAG) announced that CEO William …
-
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More
01 Nov 2019 12:33 GMT
… the agency pull an AMAG Pharmaceuticals (NASDAQ: AMAG) drug for preterm birth … in China.
THIS WEEK IN IPOS
—Cancer and inflammatory diseases drug … markets with a $36 million IPO. The South San Francisco … company priced its IPO at $12 per share, …